RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB<sub>1</sub> , CB<sub>2</sub> , GPR18 and GPR55 cannabinoid receptors.

Glenn, Nathaniel A K; Finlay, David B; Carruthers, Emma R; Mountjoy, Kathleen G; Walker, Christopher S; Grimsey, Natasha L

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB₁ , CB₂ , GPR18 and GPR55 cannabinoid receptors.

Glenn, Nathaniel A K; Finlay, David B; Carruthers, Emma R; Mountjoy, Kathleen G; Walker, Christopher S; Grimsey, Natasha L.

Afiliação

Glenn NAK; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Finlay DB; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Carruthers ER; Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Mountjoy KG; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Walker CS; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Grimsey NL; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.

Br J Pharmacol ; 2023 Apr 21.

Article em En | MEDLINE | ID: mdl-37085333

Palavras-chave

CB1; CB2; G protein-coupled receptor (GPCR); GPR18; GPR55; cannabinoid receptor; melanocortin receptor accessory protein (MRAP); receptor activity-modifying protein (RAMP)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Br J Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nova Zelândia